Course of ocular function in PRPF31 retinitis pigmentosa

Seminars in Ophthalmology

Volumn 31, Issue 1-2, 2016, Pages 49-52

  Hafler, Brian P ^a   Comander, Jason ^a   Difranco, Carol Weigel ^a   Place, Emily M ^a   Pierce, Eric A ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Inherited retinal degeneration; Retinitis pigmentosa; RNA splicing factor

Indexed keywords

RNA; EYE PROTEIN; PRPF31 PROTEIN, HUMAN;

ADENO ASSOCIATED VIRUS; AUTOFLUORESCENCE; AUTOSOMAL DOMINANT INHERITANCE; DISEASE COURSE; ELECTRORETINOGRAM; GENE; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PRPF 31 GENE; RETINITIS PIGMENTOSA; REVIEW; RNA SPLICING; VIRAL GENE THERAPY; VISUAL ACUITY; VISUAL FIELD; DEPENDOPARVOVIRUS; GENE THERAPY; GENE VECTOR; GENETICS; MUTATION;

DEPENDOVIRUS; EYE PROTEINS; GENETIC THERAPY; GENETIC VECTORS; HUMANS; MUTATION; RETINITIS PIGMENTOSA; RNA SPLICING;

EID: 84962133951     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2015.1114856     Document Type: Review

References (17)

1. Daiger SP, Bowne, SJ, Sullivan LS. Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol 2007;125(2):151-158.
2. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006;368(9549):1795-1809.
3. Sullivan LS, Bowne SJ, Reeves MJ, et al. Prevalence of mutations in eyeGENE probands with a diagnosis of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 2013;54(9):6255-6261.
4. Rio Frio T, Wade NM, Ransijn A, et al. Premature termination codons in PRPF31 cause retinitis pigmentosa via haploinsufficiency due to nonsense-mediated mRNA decay. J Clin Invest 2008;118(4):1519-1531.
5. Vithana EN, Abu-Safieh L, Pelosini L, et al. Expression of PRPF31 mRNA in patients with autosomal dominant retinitis pigmentosa: A molecular clue for incomplete penetrance? Invest Ophthalmol Vis Sci 2003; 44(10):4204-4209.
6. McGee TL, Devoto M, Ott J, et al. Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele. Am J Hum Genet 1997; 61(5):1059-1066.
7. Farkas MH, Lew DS, Sousa ME, et al. Mutations in PremRNA processing factors 3, 8, and 31 cause dysfunction of the retinal pigment epithelium. Am J Pathol 2014;184(10): 2641-2652.
8. Fishman GA, Chappelow AV, Anderson RJ, et al. Shortterm inter-visit variability of ERG amplitudes in normal subjects and patients with retinitis pigmentosa. Retina 2005;25(8):1014-1021.
9. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008;358(21):2240-2248.
10. Seiple W, Clemens CJ, Greenstein VC, et al. Test-retest reliability of the multifocal electroretinogram and humphrey visual fields in patients with retinitis pigmentosa. Doc Ophthalmol 2004;109(3):255-272.
11. Ogura S, Yasukawa T, Kato A, et al. Wide-field fundus autofluorescence imaging to evaluate retinal function in patients with retinitis pigmentosa. Am J Ophthalmol 2014; 158(5):1093-1098.
12. Berson EL, Sandberg MA, Rosner B, et al. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol 1985;99(3):240-251.
13. Grover S, Fishman GA, Birch DG, et al. Variability of fullfield electroretinogram responses in subjects without diffuse photoreceptor cell disease. Ophthalmology 2003; 110(6):1159-1163.
14. Birch DG, Locke KG, Wen Y, et al. Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. JAMA Ophthalmol 2013;131(9):1143-1150.
15. Ramachandran R, Zhou L, Locke KG, et al. A comparison of methods for tracking progression in X-linked retinitis pigmentosa using frequency domain OCT. Transl Vis Sci Technol 2013;2(7):5.
16. Fischer MD, Fleischhauer JC, Gillies MC, et al. A new method to monitor visual field defects caused by photoreceptor degeneration by quantitative optical coherence tomography. Invest Ophthalmol Vis Sci 2008;49(8):3617-3621.
17. MacLaren RE, Groppe M, Barnard AR, et al. Retinal gene therapy in patients with choroideremia: Initial findings from a phase 1/2 clinical trial. Lancet 2014; 383(9923):1129-1137.